Disease/Infection News

RSS

Fungus responsible for outbreak of Greek yogurt can threaten health systems

The fungus responsible for an outbreak of contaminated Greek yogurt last year is not harmless after all but a strain with the ability to cause disease, according to research published in mBio-, the online open-access journal of the American Society for Microbiology.

8 Jul 2014

UC Riverside discovery could lead to future development of needle-free vaccines

Ripping a page from the Star Trek script, specialized cells of the barrier that lines the inside of the intestines and airways of humans have invoked a biological version of Captain Kirk's famous command "shields up" as a first defense against invading microbes.

8 Jul 2014

Survey shows biggest barrier to receiving Human Papillomavirus vaccine

A survey of first-year Grand Valley State University students showed the biggest barrier to receiving a Human Papillomavirus (HPV) vaccine was moral or religious beliefs, or a perceived promotion of sexual behavior, according to graduate physician assistant researchers.

8 Jul 2014

Priority actions needed to tackle the Ebola crisis in West Africa according to researchers in Sierra Leone

Researchers working in Sierra Leone suggest priority actions needed to tackle the ongoing Ebola crisis in West Africa. In a letter to The Lancet, the researchers call for improvements in access to diagnostic technologies and health-care resources, as well as improved disease surveillance and health communication.

7 Jul 2014

Research on intestinal microbiota overturns vision of human gut ecosystem

An international research team within the MetaHIT consortium coordinated by INRA and involving teams from CEA, CNRS and Université d'Evry, has developed a new method to analyse the global genome, or the metagenome of the intestinal microbiota.

7 Jul 2014

Scientists develop chip for detection of RNA strand of dengue fever virus

Scientists at the Center for Research and Advanced Studies (Cinvestav) in Mexico developed a chip (also known as cDNA microarray) that allows detection of the RNA strand of the dengue fever virus.

7 Jul 2014

Researchers map unknown microorganisms in human intestinal flora

Researchers from DTU Systems Biology have mapped 500 previously unknown microorganisms in human intestinal flora as well as 800 also unknown bacterial viruses (also called bacteriophages) which attack intestinal bacteria.

7 Jul 2014

Researchers find novel inhibitor that prevents cholera toxin from binding to carbohydrates

Cholera against cholera: a novel inhibitor prevents the cholera toxin from binding to carbohydrates found on the surface of intestinal cells.

7 Jul 2014

Simple and hygienic measures can prevent campylobacter infections

In Switzerland, between 7000 and 8000 persons fall ill with a campylobacter infection annually. This makes it the most frequent bacterial disease transmitted through food.

4 Jul 2014

Metal-free chemical reaction for anti-HIV, anti-cancer and anti-bacterial drugs

A team of researchers from KU Leuven, in Belgium, has developed an economical, reliable and heavy metal-free chemical reaction that yields fully functional 1,2,3-triazoles. Triazoles are chemical compounds that can be used as building blocks for more complex chemical compounds, including pharmaceutical drugs.

4 Jul 2014

Pneumonia patients treated with azithromycin face lower risk of death, slightly increased risk of heart attack

In a study that included nearly 65,000 older patients hospitalized with pneumonia, treatment that included azithromycin compared with other antibiotics was associated with a significantly lower risk of death and a slightly increased risk of heart attack, according to a study in the June 4 issue of JAMA.

4 Jul 2014

WHO presents new framework to eliminate TB in 33 countries

The World Health Organization today, together with the European Respiratory Society, presented a new framework to eliminate tuberculosis (TB) in countries with low levels of the disease. Today there are 33 countries and territories where there are fewer than 100 TB cases per million population.

3 Jul 2014

Population centers in cool, highland regions of East Africa more vulnerable to malaria

Fine-scale climate model projections suggest the possibility that population centers in cool, highland regions of East Africa could be more vulnerable to malaria than previously thought, while population centers in hot, lowland areas could be less vulnerable, according to a team of researchers. The team applied a statistical technique to conventional, coarse-scale climate models to better predict malaria dynamics at local levels.

3 Jul 2014

New meta-analysis highlights significant gaps in hepatitis C care

A new meta-analysis published online in PLOS ONE by infectious disease and epidemiology specialists from the Perelman School of Medicine at the University of Pennsylvania highlights significant gaps in hepatitis C care that will prove useful as the U.S. health care system continues to see an influx of patients with the disease because of improved screening efforts and new, promising drugs.

3 Jul 2014

Study reveals mechanism underlying abnormal fat accumulation in HIV patients

Building upon their earlier research on the biology of fat metabolism, Joslin scientists discovered that microRNAs -small RNA molecules that play important roles in regulation in many types of tissue - play a major role in the distribution and determination of fat cells and whole body metabolism.

3 Jul 2014

Ralphs Pharmacies continue to offer Tdap vaccinations for whooping cough in Southern California

As the number of pertussis cases, also known as whooping cough, reaches epidemic proportions in California, Ralphs Pharmacies continue to offer Tdap (tetanus, diphtheria, pertussis) vaccinations at its 85 in-store pharmacies throughout Southern California.

2 Jul 2014

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

Isis Pharmaceuticals, Inc. announced today that it has earned a $1 million payment from GlaxoSmithKline related to the advancement of its program to develop antisense drugs to treat hepatitis B virus (HBV).

2 Jul 2014

Clear advances in the fight against tuberculosis are within reach, say immunologists

Leading immunologists expect to see some clear advances in the fight against tuberculosis, an infectious disease that is widespread the world over. Professor Stefan Kaufmann, Director at the Max Planck Institute for Infection Biology in Berlin, echoed these sentiments at today's launch of the scientific programme for the 64th Lindau Nobel Laureate Meeting at Lindau, Germany.

2 Jul 2014

MedImmune initiates MEDI8897 phase I clinical studies for treatment of RSV infections

AIMM Therapeutics, a leading human therapeutic antibody company, today announced that its partner MedImmune, LLC, the global biologics unit of AstraZeneca, has initiated phase I clinical studies with MEDI8897, a best-in-class antibody for the treatment of respiratory syncytial virus (RSV) infections in young, at risk children.

2 Jul 2014

Lab M launches µPrep Half Fraser Broth ISO (+FAC) for use in isolation of Listeria spp. from food

Lab M has launched µPrep Half Fraser Broth ISO (+FAC), the latest addition to the company’s µPrep range of convenient, ready-to-reconstitute microbiological culture media. Designed for use in the isolation of Listeria spp. from foodstuffs, this complete primary enrichment broth is supplied sterile in a highly robust bag, which simply requires the addition of water.

2 Jul 2014

Disease/Infection News

Fungus responsible for outbreak of Greek yogurt can threaten health systems

UC Riverside discovery could lead to future development of needle-free vaccines

Survey shows biggest barrier to receiving Human Papillomavirus vaccine

Priority actions needed to tackle the Ebola crisis in West Africa according to researchers in Sierra Leone

Research on intestinal microbiota overturns vision of human gut ecosystem

Scientists develop chip for detection of RNA strand of dengue fever virus

Researchers map unknown microorganisms in human intestinal flora

Researchers find novel inhibitor that prevents cholera toxin from binding to carbohydrates

Simple and hygienic measures can prevent campylobacter infections

Metal-free chemical reaction for anti-HIV, anti-cancer and anti-bacterial drugs

Pneumonia patients treated with azithromycin face lower risk of death, slightly increased risk of heart attack

WHO presents new framework to eliminate TB in 33 countries

Population centers in cool, highland regions of East Africa more vulnerable to malaria

New meta-analysis highlights significant gaps in hepatitis C care

Study reveals mechanism underlying abnormal fat accumulation in HIV patients

Ralphs Pharmacies continue to offer Tdap vaccinations for whooping cough in Southern California

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

Clear advances in the fight against tuberculosis are within reach, say immunologists

MedImmune initiates MEDI8897 phase I clinical studies for treatment of RSV infections

Lab M launches µPrep Half Fraser Broth ISO (+FAC) for use in isolation of Listeria spp. from food

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News